Extension without change of a currently approved collection
No
Regular
12/23/2025
Requested
Previously Approved
36 Months From Approved
12/31/2025
131
86
5,073
3,183
0
0
This information collection implements
section 522 of the Federal Food, Drug, and Cosmetic Act, which
governs the postmarket surveillance of medical devices. Respondents
to the information collection are medical device manufacturers who
must conduct surveillance in accordance with statutory orders
issued by FDA in support of the clearance or approval of certain
devices. The information collection is intended to ensure the
continued safety of medical devices.
US Code:
21
USC 360l Name of Law: Postmarket Surveillance
Our estimated burden for the
information collection reflects an increase of 1,890 total burden
hours and a corresponding increase 45 total annual responses. This
increase is based on internal FDA tracking data. The number of
respondents varies annually, subject to the number of original
plans, plan changes, and interim and final reports (which are
dependent on enrollment progress for each study) received by
FDA.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.